Decoding 9 Analyst Evaluations For Axsome Therapeutics
Decoding 9 Analyst Evaluations For Axsome Therapeutics
解码关于axsome therapeutics的9位分析师评估
Axsome Therapeutics (NASDAQ:AXSM) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去三个月中,Axsome Therapeutics(纳斯达克:AXSM)受到9名分析师的分析,展示了从看好到看淡的不同观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级,展示了过去30天内不断变化的情绪,并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Axsome Therapeutics, revealing an average target of $129.89, a high estimate of $190.00, and a low estimate of $95.00. Surpassing the previous average price target of $127.11, the current average has increased by 2.19%.
分析师为Axsome Therapeutics设定了12个月的目标价,揭示了平均目标值为129.89美元,最高估值为190.00美元,最低估值为95.00美元。当前平均价值上涨了2.19%,超过了之前的平均目标价值127.11美元。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级:更深入的了解
The standing of Axsome Therapeutics among financial experts becomes clear with a...
通过对最近分析师行动进行...
登录免费看全文
登录/注册